In many prokaryotes, type III CRISPR-Cas systems detect and degrade invasive genetic elements by an RNA-guided, RNA-targeting multisubunit interference complex that possesses dual RNase and DNase activities. The CRISPR-associated protein Csm6 additionally contributes to interference by functioning as a standalone ribonuclease that degrades invader RNA transcripts, but the mechanism linking invader sensing to Csm6 activity is not understood. Here we show that Csm6 proteins are activated through a second messenger generated by the type III interference complex. Upon target RNA binding by the type III interference complex, the Cas10 subunit converts ATP into a cyclic oligoadenylate product, which allosterically activates Csm6 by binding to its CARF domain. CARF domain mutations that abolish allosteric activation inhibit Csm6 activity in vivo, and mutations in the Cas10 Palm domain phenocopy loss of Csm6. Together, these results point to a hitherto unprecedented mechanism for regulation of CRISPR interference that bears striking conceptual similarity to oligoadenylate signalling in mammalian innate immunity.
ABSTRACT
In many prokaryotes, type III CRISPR-Cas systems detect and degrade invasive genetic elements by an RNA-guided, RNA-targeting multisubunit interference complex that possesses dual RNase and DNase activities. The CRISPR-associated protein Csm6 additionally contributes to interference by functioning as a standalone ribonuclease that degrades invader RNA transcripts, but the mechanism linking invader sensing to Csm6 activity is not understood. Here we show that Csm6 proteins are activated through a second messenger generated by the type III interference complex. Upon target RNA binding by the type III interference complex, the Cas10 subunit converts ATP into a cyclic oligoadenylate product, which allosterically activates Csm6 by binding to its CARF domain. CARF domain mutations that abolish allosteric activation inhibit Csm6 activity in vivo, and mutations in the Cas10 Palm domain phenocopy loss of Csm6. Together, these results point to a hitherto unprecedented mechanism for regulation of CRISPR interference that bears striking conceptual similarity to oligoadenylate signalling in mammalian innate immunity.
Clustered regularly interspaced short palindromic repeat (CRISPR) loci and CRISPRassociated (Cas) proteins constitute an adaptive prokaryotic immune system directed against invasive genetic elements such bacteriophages and plasmids [1] [2] [3] . Class 1 CRISPR-Cas systems, comprising type I, III and IV systems, mediate nucleic acid interference by means of a multiprotein-RNA complex composed of a processed CRISPR RNA (crRNA) and several Cas protein subunits 4 . In type III systems, the interference complex (known as Csm complex in type III-A/D systems and Cmr complex in type III-B/C systems) is assembled from the signature multidomain protein Cas10 (Csm1 in type III-A/D or Cmr2 in type III-B/C systems) and additional Cas proteins (Csm2-5 in type III-A/D, or Cmr1 and Cmr3-6 in type III-B/C) 5 . In these systems, interference is transcription-dependent and is thought to be initiated by the crRNA-guided interference complex binding to the nascent transcript of the target gene [6] [7] [8] .
The target RNA-bound complex functions as a sequence-specific endoribonuclease (RNase) to cleave the bound target RNA and in addition has a target RNA-stimulated non-specific deoxyribonuclease (DNase) activity that cleaves single-stranded DNA 6, [9] [10] [11] [12] .
Members of the Csm6 or the related Csx1 protein families are frequently encoded within type III CRISPR-Cas systems 13 . These proteins are characterized by the presence of an N-terminal CRISPR-Associated Rossmann Fold (CARF) domain and a C-terminal Higher
Eukaryotes and Prokaryotes Nucleotide-binding (HEPN) RNase domain 13, 14 . In the Staphylococcus epidermidis type III system, Csm6 is required for efficient antiplasmid and antiviral immunity 15, 16 . Csm6 proteins function as RNases [16] [17] [18] that have been shown to nonspecifically degrade invader-derived RNA transcripts, providing an additional interference mechanism that complements the nuclease activities of the type III interference complex 16 . As
Csm6 ribonucleases do not appear to physically associate with the Cas10-containing interference complex [19] [20] [21] , the mechanism linking their nuclease activity to invader recognition is not known.
Allosteric activation of CRISPR-associated Csm6 ribonucleases
We previously showed that Csm6 is a homodimeric RNase that contains a conserved active site at the dimer interface of the HEPN domains 17 . Our structural studies further revealed that Csm6 contains a conserved, positively charged cleft at the dimeric interface of the CARF domains. Given the dimeric architecture of Csm6 and the fact that the CARF domain is a variant of the Rossmann fold, which is typically found in nucleotide-binding proteins 13 , we hypothesized that the ribonuclease activity of Csm6 might be allosterically regulated by a twofold symmetric nucleotide ligand. To address this, we initially tested the ribonuclease activity of Thermus thermophilus Csm6 (TtCsm6) in the presence of cyclic bis-(3'-5')-adenylate (c-di-AMP), a well-known bacterial second messenger 22 . We observed that TtCsm6 activity was substantially increased in the presence of c-di-AMP (Extended Data Fig. 1 ). However, the stimulatory effect was batch-dependent; c-di-AMP batches prepared by chemical synthesis were active, while enzymatically-generated c-di-AMP had no effect (Extended Data Fig. 1 ),
suggesting that activation was due to a contaminating by-product of chemical synthesis.
Because chemical synthesis of cyclic dinucleotides typically involves cyclization of a linear dinucleotide precursor 23 , we speculated that the true activator might be a linear or cyclic oligoadenylate nucleotide generated by dinucleotide concatenation. To test this hypothesis, we first analysed the activation of TtCsm6 by linear tetraadenylates in ribonuclease activity assays that employed either a fluorophore-labelled ssRNA substrate (Fig. 1a) or a fluorogenic RNA substrate containing a fluorophore and a quencher whose cleavage results in a quantifiable increase in fluorescence signal (Fig. 1b, Extended Data Fig. 2 ). TtCsm6 was potently activated by tetraadenylate (A4); moreover, the presence of a 2',3'-cyclic phosphate group further potentiated activation (Fig. 1a, b) . Profiling a panel of oligonucleotides of varying lengths revealed that the 2',3'-cyclic phosphate-terminated tetradenylate (A4>P) had the strongest effect on TtCsm6 (Fig. 1c) , although longer oligoadenylates (oligoA) were also modestly active (Fig 1c, Extended Data Fig. 2b ). To test whether oligoA-mediated activation was a general property of Csm6 enzymes, we additionally examined evolutionarily divergent 
The CARF domain of Csm6 is an oligoA sensor
To quantify the activation of Csm6 ribonucleases, we analysed the ribonuclease activity of EiCsm6 as a function of A6>P concentration (Fig. 2a) . Plotting initial reaction velocity against effector concentration and fitting the curve by non-linear regression analysis using a log(dose)-versus-response relationship gave a half-maximal effective concentration (EC 50 ) of ~60 nM (Fig. 2b) . Since HEPN domain ribonucleases typically bind their RNA substrates with micromolar affinities 24, 25 , this strongly suggests that the A6>P effector is recognized by an allosteric binding site in EiCsm6 that is distinct from the ribonuclease active site in the HEPN domain. Based on the proposed function of CARF domains in binding nucleotide ligands 13 ,
we hypothesized that the CARF domain functions as the allosteric sensor of oligoA. To test this, we engineered a glutamine-to-alanine substitution in the conserved CARF domain motif Ser112-Gln116 in EiCsm6 (Extended Data Fig. 4a ), which maps to the dimeric CARF domain interface in TtCsm6 and would correspond to the ligand-binding face in a canonical
Rossmann fold domain (Extended Data Fig. 4b) . In contrast to wild-type EiCsm6, the Q116A EiCsm6 mutant (dEiCsm6 CARF ) no longer responded to A6>P, indicating that disruption of the CARF domain motif abrogated allosteric activation (Fig. 2c,d ). This result implies that the Csm6 CARF domain functions as the allosteric sensor of oligoA ligands and suggests that effector binding at the CARF domain dimer interface is transduced to the ribonuclease active site at the dimeric interface of the HEPN domains.
Csm6 is activated by a second messenger generated by the type III interference complex
Since Csm6 proteins function in the context of type III CRISPR-Cas systems, we speculated that allosteric activation of Csm6 is dependent on an enzymatic activity harboured by the multisubunit type III CRISPR interference complex. Guided by a processed crRNA, the Cas10-containing complex binds to a target RNA, which leads to sequence-specific target RNA cleavage and concurrently stimulates sequence non-specific DNase activity of the complex [9] [10] [11] [12] . Given that Csm6 proteins have not been found to be physically associated with the interference complex, we hypothesized that the complex would additionally generate a diffusible allosteric activator of Csm6 in a target RNA-dependent manner. We exploited the Enterococcus italicus type III-A system and co-expressed CRISPR-associated genes csm1-csm6 and cas6 together with two repeat-spacer units of the endogenous CRISPR array in
Escherichia coli from a single polycistronic mRNA (Extended Data Fig. 5a ). ) resulted in loss of RNase activity (Extended Data Fig. 5c ).
To test whether the allosteric effector of Csm6 is produced by the type III interference complex, we incubated the EiCsm(1-5) complex together with a target RNA oligonucleotide in the presence of ATP and magnesium ions at 37 o C. We subsequently heat-inactivated the complex, removed precipitated proteins by centrifugation and added a fraction of the deproteinized supernatant to an assay reaction mixture containing EiCsm6 and the fluorogenic RNA substrate. We observed robust activation of EiCsm6 by the supernatant, with 1% of the added supernatant having the same effect as 500 nM A6>P, suggesting that the EiCsm(1-5) complex produces a diffusible molecular product capable of activating EiCsm6 (Fig. 3a) . Activator production was dependent on the presence of ATP, which could not be substituted by any of the three other nucleotide triphosphates, and required Mg 2+ ions, as addition of EDTA was inhibitory (Fig. 3b) . Moreover, the activator was only produced in the presence of a cognate target RNA but not when a non-cognate control RNA was used instead (Fig. 3b) . Together, these results show that the EiCsm(1-5) complex generates a diffusible
Csm6 activator by an ATP-, magnesium-and target RNA-dependent mechanism.
Since crRNA-guided target RNA cleavage by the Csm(1-5) complex yields hexanucleotide products that could potentially act as Csm6 activators, we tested whether the ribonuclease activity of the EiCsm(1-5) complex was required to generate the EiCsm6 activator. Supernatant from a reaction containing EiCsm(1-5) complex in which the crRNAguided RNase activity was abolished by the D32A mutation in the Csm3 subunits activated EiCsm6 even more strongly than the wild-type complex (Fig. 3c) . These results indicate that activator generation is dependent on target RNA binding but activator is not generated by cleavage of target RNA. Moreover, the observed hyperactivity of the RNase-deficient EiCsm(1-5) complex indicates that production of the Csm6 activator is itself allosterically activated by target RNA binding by the type III interference complex.
The Palm domain of Cas10 converts ATP into a cyclic oligoA product
Having ruled out the crRNA-guided target RNA cleavage activity as the source of the allosteric effector, we examined other enzymatic activities within the type III interference complex. The Cas10 (Csm1) subunit of the complex contains two putative catalytic domains. In the presence of cognate target RNA, the EiCsm(1-5) complex converted ATP into a product displaying lower electrophoretic mobility. In contrast, product formation did not occur when a non-cognate RNA was supplied (Fig. 4b) .
Moreover, the activity was dependent on the presence of an intact GGDD motif in the Palm domain, whereas inactivating point mutations in the Cas10 HD domain or in Csm3 had no effect ( Fig. 4b) . Together, these results indicate that within the Csm(1-5) complex, the Cas10
Palm domain is allosterically activated by target RNA binding to generate a well-defined oligoA product by ATP polymerization. 
In vivo activity of Csm6 is dependent on the oligoadenylate cyclase activity of the Csm complex
In the S. epidermidis type III-A CRISPR-Cas system, the RNase activities of Csm6 and Csm3 result in the degradation of phage transcripts, which is required for efficient anti-phage immunity when the target site is located in a gene transcript expressed late during infection 16 .
To corroborate our biochemical studies, we tested whether the in vivo activity of Csm6 depends on allosteric activation by oligoA generated by Cas10. We first determined whether (Fig. 5a) . These results suggest that oligoA sensing by the Csm6 CARF domain is required for Csm6 function in vivo and also affirm that Csm6 activation relies on a diffusible ligand rather than a direct physical interaction with the type III interference complex.
We then proceeded to test whether the function of the endogenous Csm6 protein is dependent on the enzymatic activity of the Palm domain of Cas10. To this end, we infected staphylococci containing the S. epidermidis system programmed to target the late-expressed gene gp43 with phage Φ NM1γ6. Whereas the activity of either Csm3 or Csm6 is sufficient to support immunity at low multiplicity of infection (MOI ~1) 16 , at high MOI (~30) mutation of the Csm6 HEPN RNase domain (dCsm6 HEPN ) resulted in a significant reduction of cell survival, even in the presence of active Csm3 (Fig. 5b) . Mutation of the GGDD motif in the Cas10 subunit (dSeCas10 Palm ) resulted in similar reduction in cell survival as that observed for the dSeCsm6 HEPN mutant (Fig. 5b) . It was previously reported that this mutation in S. epidermidis
Cas10 prevents DNA cleavage in vitro 6 , and therefore the defect in immunity could be attributed to a functional role of the Palm domain in Csm6 activation, DNA cleavage or both. We conclude that the type III interference complex is not only a crRNA-guided RNase and DNase, but also a cyclic oligoadenylate synthetase (Fig. 6) . domain proteins, such as Csa3 13, 32 , that appear to be transcription factors rather than nucleases raises the possibility that CRISPR-Cas systems also use cyclic oligoA signalling for transcriptional regulation, either within their own loci or to induce other genome defence mechanisms or stress response pathways upon invader detection. mM KCl, and 250 mM Imidazole. The complex was concentrated and further directly purified by size-exclusion chromatography using two Superose-6 (10/300) columns connected in tandem, or a Sephacryl S-300 (26/600) column (GE Healthcare), in buffer containing 20 mM HEPES pH 7.5, 300 mM KCl, and 5 mM MgCl 2 . Appropriate fractions were pooled and concentrated using 100,000 MWCO centrifugal filters (Merck Millipore), and samples were analysed by SDS-PAGE using a 4-15% gradient polyacrylamide gel (Bio-Rad). All mutant complexes were purified using the same protocol as for the wild type complex. The concentration of EiCsm(1-5) complex was calculated according to a formula that takes nucleic acid contamination (i.e. crRNA) into consideration. Fractions were pooled, dried under vacuum and dissolved in H 2 O.
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